Beltrán-Rivera LY, Moreno-Ruiz LA, Góngora-Carlín MA, Fabián-Reyes TD, Facio-Sánchez EA

Language: Spanish
References: 9
Page: 20-25
PDF size: 464.01 Kb.

ABSTRACT

Objective: To determine the permanence of the TCu 380A IUD inserted after the obstetric event in the Dr. Aurelio Valdivieso Hospital.
Material and Methods: Cross-sectional and descriptive study carried out in patients who concluded their pregnancy, between October 1, 2016 and March 31, 2017, at the Dr. Aurelio Valdivieso General Hospital (Oaxaca, Mexico) and who accepted the placement of the TCu 380A intrauterine device during the postpartum period. and before discharge from the hospital. Study variables: number of pregnancies, termination of these, doctor responsible for the placement, technique and permanence. The statistical analysis implemented was univariate.
Results: The study was conducted in 182 patients with a mean age of 23 years, a minimum of 14 years and a maximum of 43 years. In the monitoring of the permanence of the IUD TCu 380A with 42.31% (77) was found in situ, 28.57% (52) in poor position, and 0.55% (1) was expelled.
Conclusions: The permanence of the intrauterine device seems to have a close relationship with the correct way to insert it and, of course, with the accumulated experience of the doctor. In the first insertions the doctor must be supervised by another one of greater experience or, simply, with the surveillance of the assigned doctors.

REFERENCES

1. Madden T. Intrauterine contraception: Devices, candidates, and selection G Dean, AB Goldberg - Up To Date, 2016. https://www.uptodate.com/contents/intrauterinecontraception- candidates-and-device-selection

2. National Institute for Health and Clinical Excellence, NICE clinical guideline no 30 2005. Long-acting reversible contraception. https://www.nice.org.uk/guidance/cg30

3. Faculty of Sexual & Reproductive Healthcare (FSRH) (2015). Intrauterine Contraception. https://www.fsrh.org/ standards-and-guidance/documents/ceuguidanceintrauterinecontraception/

4. Lara R, Velázquez N, Reyes E, Baca R. Dispositivo intrauterino posplacenta. Hilos guía no visibles. Ginecol Obstet Mex 2011;80(3):201-7.

5. OMS. Estrategias para la programación de la planificación familiar postparto, 2014. http://www.who.int/reproductivehealth/ publications/family_planning/ppfp_strategies/es/

6. Martínez BM, Navalón BZ, Labrador BR. Anticoncepción intrautrerina. Protocolos SEGO-SEC.

7. Hardeman J, Barry DW. Intrauterine Devices: An Update, University of Arizona, Tucson, Arizona. Am Fam Physician. 2014;89(6):445-50. https://www.aafp.org/afp/2014/0315/ p445.html

8. Veloso MD, Lobos A, et al. Control ecográfico post inserción de dispositivo intrauterino. Revista Chilena de Obstetricia y Ginecología 2011;76(1): 15-20. http://dx.doi.org/10.4067/ S0717-75262011000100004

9. Iglesias L. Control ecográfico del dispositivo intrauterino. (Ponencias). V Congreso de la Sociedad Española de Contracepción. (1994). http://hosting.sec.es/descargas/ 2000_Congreso_SEC/pdf/p4b.pdf